Wordt geladen...
Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma
BACKGROUND: In the clinic, how to stratify renal cell carcinoma (RCC) patients with different risks and to accurately predict their prognostic outcome remains a crucial issue. In this study, we assessed the expression and prognostic value of gankyrin in RCC patients. METHODS: The expression of ganky...
Bewaard in:
| Gepubliceerd in: | EBioMedicine |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6354735/ https://ncbi.nlm.nih.gov/pubmed/30558998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2018.12.011 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|